MyFinsight
Home
About
Contact
Back
Income Statement
Sigyn Therapeutics, Inc. (SIGY)
source: myfinsight.com
Download
Download image
Net loss
-$1,451,187
(-68.28%↓ Y/Y)
Loss before income
taxes
-$1,451,187
(-68.28%↓ Y/Y)
Total other expense
-$981,674
(-278.18%↓ Y/Y)
Loss from operations
-$469,513
(22.11%↑ Y/Y)
Other income
$5,797
Inducement of preferred
shares
$845,901
Interest expense - debt
discount
$42,175
(-63.87%↓ Y/Y)
Interest expense -
original issuance costs
$81,017
(-43.05%↓ Y/Y)
Modification of warrants
$17,505
Total operating
expenses
$469,513
(-22.11%↓ Y/Y)
Interest expense
$873
(53.43%↑ Y/Y)
Stock based
compensation
$50,000
(33.33%↑ Y/Y)
General and
administrative
$412,023
(26.83%↑ Y/Y)
Marketing expenses
$8
(0.00%↑ Y/Y)
Research and development
$7,482
(-96.89%↓ Y/Y)
Back